Los mejores oncohematólogos de Quimioterapia del linfoma en Turquía — TOP-29 médicos

El Prof. Baytan es un médico que se graduó de la Facultad de Medicina de la Universidad de Ankara en 1992 y se convirtió en Especialista en Medicina en la Facultad de Medicina de la Universidad de Uludağ, Departamento de Enfermedades Infantiles. Tiene experiencia en el diagnóstico y tratamiento de cánceres infantiles, leucemia, anemia y otras enfermedades. Tiene 15 artículos publicados en revistas arbitradas internacionales, 9 textos completos presentados y publicados en reuniones científicas internacionales, 3 libros/capítulos de libros escritos y 8 artículos publicados en revistas arbitradas locales.

El Dr. Özer Akgül es un oncólogo radioterápico turco experimentado, con un MD de la Facultad de Medicina de la Universidad de Uludag (Bursa) y residente del Hospital Universitario de Ege. Tiene competencia en la supervisión de tendencias oncológicas, el logro de objetivos establecidos, la comprensión de las necesidades del mercado y el desarrollo de estrategias. Sus áreas de interés incluyen cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer de recto, cáncer de cabeza y cuello, cáncer de cuello uterino, cáncer gástrico y tumores cerebrales. Ha asistido a cursos e investigado en Nanobiotecnología, Genética, Oncología Médica, Cánceres Ginecológicos, Bioinformática, Métodos Bionanotecnológicos, Radiobiología Clínica, Radiofísica Médica, Oncología Radioterápica Basada en Evidencia, Radioterapia y Quimioterapia Guiadas por Imágenes, Escuela Clínica de Técnicas Avanzadas de Varian, Estereotáctica Radioterapia y Varian Advanced Imaging (IGRT). Es miembro de TROD, Asociación Médica Turca, MOKAD y ESTRO.

El Prof. Songul Serefhanoglu es hematólogo en ISU Medical Park desde 2019 y ha sido director y presidente del Departamento de Hematología de Adultos del Sisli Memorial Hospital, Estambul desde 2019. Completó su educación médica en la Universidad de Firat, Elazig/Turquía (1994-2000). ), Medicina Interna de la Universidad Inonu, Malatya/Turquía (2001-2005), y Hematología de la Universidad Hacettepe, Ankara/Turquía (2006-2009). Ha estado involucrado en el trasplante de células madre hematopoyéticas periféricas, con un promedio de 100-120/año.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

El Dr. X es un oncólogo médico con más de 30 años de experiencia. Tiene una Educación Médica de la Universidad de Estambul, especialización en Medicina Interna y una Especialización en Oncología Médica del Instituto de Oncología de la Universidad de Estambul. Es miembro de la Asociación de Oncología Médica, la Asociación de Cáncer de Pulmón, ESMO, ASCO y la Cámara Médica de Estambul.

Especialista en Oncología Médica con experiencia en cáncer de pulmón, mama, colorrectal, gástrico, hígado, riñón, páncreas, estómago, próstata y útero. Experiencia en quimioterapia, inmunoterapia, fitoterapia, ozonoterapia, quimioterapia hipertérmica, cáncer GIS y cáncer ginecológico y genitourinario. Miembro del Grupo Turco de Oncología, Asociación de Oncología Médica, Asociación Turca de Investigación y Guerra del Cáncer, Sociedad Europea de Oncología Médica, Sociedad Europea de Oncología Ginecológica y Asociación Internacional para el Estudio del Cáncer de Pulmón.